Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Account Payables: 2010-2019

Historic Change in Account Payables for Fortress Biotech (FBIO) over the last 6 years, with Dec 2019 value amounting to -$149,000.

  • Fortress Biotech's Change in Account Payables was N/A to -$19,000 in Q4 2020 from the same period last year, while for Dec 2020 it was -$288,000, marking a year-over-year change of. This contributed to the annual value of -$149,000 for FY2019, which is 547.83% down from last year.
  • Latest data reveals that Fortress Biotech reported Change in Account Payables of -$149,000 as of FY2019, which was down 547.83% from -$23,000 recorded in FY2018.
  • In the past 5 years, Fortress Biotech's Change in Account Payables registered a high of $172,000 during FY2017, and its lowest value of -$149,000 during FY2019.
  • Moreover, its 3-year median value for Change in Account Payables was -$23,000 (2018), whereas its average is $0.
  • Data for Fortress Biotech's Change in Account Payables shows a maximum YoY slumped of 547.83% (in 2019) over the last 5 years.
  • Yearly analysis of 3 years shows Fortress Biotech's Change in Account Payables stood at $172,000 in 2017, then crashed by 113.37% to -$23,000 in 2018, then slumped by 547.83% to -$149,000 in 2019.